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Loss of fructose-1,6-bisphosphatase induces glycolysis and 
promotes apoptosis resistance of cancer stem-like cells: an 
important role in hexavalent chromium-induced carcinogenesis
Jin Dai1, Yanli Ji1, Wei Wang1, Donghern Kim1, Leonard Yenwong Fai1, Lei Wang2, Jia Luo3, 
and Zhuo Zhang1
1Department of Toxicology and Cancer Biology, 1095 Veterans Drive, University of Kentucky, 
Lexington, KY 40536
2Center for Research on Environmental Diseases, 1095 Veterans Drive, University of Kentucky, 
Lexington, KY 40536
3Department of Pharmacology and Nutritional Sciences, 1095 Veterans Drive, University of 
Kentucky, Lexington, KY 40536
Abstract
Hexavalent chromium (Cr(VI)) compounds are confirmed human carcinogens for lung cancer. Our 
previous studies has demonstrated that chronic exposure of human bronchial epithelial BEAS-2B 
cells to low dose of Cr(VI) causes malignant cell transformation. The acquisition of cancer stem 
cell-like properties is involved in the initiation of cancers. The present study has observed that a 
small population of cancer stem-like cells (BEAS-2B-Cr-CSC) exists in the Cr(VI)-transformed 
cells (BEAS-2B-Cr). Those BEAS-2B-Cr-CSC exhibit extremely reduced capability of generating 
reactive oxygen species (ROS) and apoptosis resistance. BEAS-2B-Cr-CSC are metabolic inactive 
as evidenced by reductions in oxygen consumption, glucose uptake, ATP production, and lactate 
production. Most importantly, BEAS-2B-Cr-CSC are more tumorigenic with high levels of cell 
self-renewal genes, Notch1 and p21. Further study has found that fructose-1,6-bisphosphatase 
(FBP1), an rate-limiting enzyme driving glyconeogenesis, was lost in BEAS-2B-Cr-CSC. Forced 
expression of FBP1 in BEAS-2B-Cr-CSC restored ROS generation, resulting in increased 
apoptosis, leading to inhibition of tumorigenesis. In summary, the present study suggests that loss 
of FBP1 is a critical event in tumorigenesis of Cr(VI)-transformed cells.
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Introduction
Glucose homeostasis is controlled by the catabolic glycolysis/oxidative phosphorylation 
(OXPHOS) and the anabolic gluconeogenesis pathway. Cancer cells prefer aerobic 
glycolysis which metabolizes glucose to lactate. Aerobic glycolysis, maximizing ATP 
production, does not require an increase in mitochondrial capacity (Fan et al., 2013). The 
occurrence of Warburg effect indicates the activation of oncogenic signaling, resulting in 
promotion of glucose uptake and anabolic metabolism (Fan et al., 2013). Fructose-1, 6-
bisphosphatase (FBP1), a rate-limiting enzyme in gluconeogenesis, catalyzes the hydrolysis 
of fructose-1, 6-bisphosphate (F-1, 6-BP) to fructose 6-phosphate and inorganic phosphate. 
It has been reported that FBP1 is lost in gastric cancer (Liu et al., 2010), hepatocellular 
carcinoma and colon cancer (Chen et al., 2011), breast cancer (Dong et al., 2013), lung 
cancer (Zhang et al., 2016), and kidney cancer (Alderton, 2014). Loss of FBP1 is correlated 
with advanced tumor stage and poor prognosis (Chen et al., 2011; Zhang et al., 2016).
Cancer recurrence despite local and/or systemic therapy suggests the existence of a cell 
population with enormous capacity for self-renewal and regeneration, a biological function 
generally limited to normal somatic stem cells. Cancer stem cells (CSCs), referred to cancer 
initiating cells, are a phenotypically distinct population that possesses tumorigenic potential. 
Similar to cancer cells, CSCs utilize aerobic glycolysis for biosynthesis and energy 
requirement (Dong et al., 2016). CSCs consume more reduced nicotinamide adenine 
dinucleotide (NADH) and ADP to produce more glycolysis intermediates than cancer cells 
(Wang et al., 2014). In CSCs, many metabolic enzymes exhibit both catalytic and 
transcriptional activities to maintain the metabolic characteristics and to activate stem-like 
properties. Low level of FBP1 is beneficial to CSCs due to (a) inductions of superiority of 
glycolysis and increased glucose uptake, facilitating the production of glycolysis 
intermediates and the energy supply in CSCs during hypoxia and (b) inhibition of ROS 
generation induced by mitochondrial complex1, protecting CSCs from oxidative stress 
(Dong et al., 2016).
Hexavalent chromium (Cr(VI)) compounds are confirmed human carcinogens by 
International Agency for Research on Cancer (IARC) and US Environmental Protection 
Agency (EPA). Chronical Cr(VI) exposure through environment or occupation is associated 
with lung cancer (Langard, 1990; Woodruff et al., 1998). Although the mechanisms of 
Cr(VI) carcinogenesis is still unclear, it is believed that reactive oxygen species (ROS) play 
an important role (Shi and Dalal, 1989; Stohs et al., 2000; Yao et al., 2008; Wang et al., 
2011). Our previous studies have demonstrated that once the cells are malignantly 
transformed, the capacity of generating ROS is reduced, resulting in apoptosis resistance and 
tumorigenesis of those transformed cells (Kim et al., 2015). Mitochondria is the main source 
of ROS generation. Dysfunction of mitochondria in cancer cells results in an increase in 
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aerobic glycolysis (Boland et al., 2013). Linkage between the perturbed metabolism and 
reduced capacity of ROS generation in Cr(VI)-transformed cells are unknown. Especially 
tumorigenic effect of CSCs remains to be investigated. It has been reported that ROS 
generation was reduced in the FBP1 mutant cells in response to treatment with 
methylmethane sulfonate, an alkylating agent (Kitanovic and Wolfl, 2006). Low ROS levels 
in CSCs are critical for the maintenance of self-renewal of hematopoietic stem cells and 
human and mouse breast CSCs (Diehn et al., 2009). Inhibition of FBP1 caused delayed ROS 
generation, resulting in increased survival of aged cells (Kitanovic and Wolfl, 2006).
The present study investigated the self-renewal and proliferation of CSCs isolated from 
Cr(VI)-transformed cells and their ability for driving tumorigenesis. The present study also 
investigated the mechanism of apoptosis resistance of those CSCs and metabolic switch to 
glycolysis.
Materials and Methods
Chemicals and reagents
Sodium dichromate dehydrate (Na2Cr2O7) was from Sigma (St Louis, MO). Cisplatin was 
from Enzo Life Sciences (Farmingdale, NY). Dulbecco’s modified Eagle’s medium 
(DMEM), Defined keratinocyte serum-free medium, fetal bovine serum (FBS), and Oligo 
(dT)20 and AccuPrime Taq DNA Polymerase High Fidelity were from Invitrogen (Carlsbad, 
CA). Bradford Protein Assay Reagent was from Bio-Rad (Hercules, CA). RNeasy Mini kit 
and plasmid prep kit were from Qiagen (Valencia, CA). M-MLV reverse transcriptase was 
from Promega (Madison, WI). Perfecta Sybr Green Fastmix was from Quanta Biosciences 
(Gaithersburgh, MD). 5-(and -6)-chloromethyl-2, 7-dichlorodihydrofluorescein diacetate, 
acetyl ester (CM-H2DCFDA) and CellROX deep red reagent were from Molecular Probes 
(Eugene, OR). Antibodies against NQO1, GAPDH, and β-actin were obtained from Santa 
Cruz (Santa Cruz, CA). Antibody against FBP1 was from Sigma (St Louis, MO). Antibody 
against SOD2 was from Millipore (Billerica, MA). Antibodies against Notch1, p21, cyclin 
D1, Bcl-2, Bcl-xL, PARP, AP1/c-jun, cleaved caspase 3, and cleaved caspase 9 were from 
Cell Signaling Tech (Danvers, MA). Enhanced chemiluminescence reagent was from 
Amersham (Pittsburgh, PA). Matrigel was from BD Biosciences (San Jose, CA).
Cell culture and treatment
The human bronchial epithelial cell line BEAS-2B was obtained from the American Type 
Culture Collection (Rockville, MD). Cells were maintained in DMEM supplemented with 
10% heat-inactivated FBS and 1% penicillin–streptomycin at 37°C, 5% CO2. The cells were 
exposed continuously to Na2Cr2O7 (100 nM) in the media for 3 months and transformed 
cells were obtained by soft agar colony formation assay as described previously (Son et al., 
2013). A single colony from soft agar was picked up and continued to growth. These cells 
are considered as Cr(VI)-transformed cells.
Isolation and expansion of spheroid-derived cells from Cr(VI)-transformed BEAS-2B cells
The transformed BEAS-2B cells (1×106 cells) were re-suspended in serum-free medium 
with Matrigel basement membrane matrix (BD Biosciences) at a 1:1 ratio (total volume = 
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100 μL) and subcutaneously injected into the flanks of nude mice. After diameter of the 
tumor reached about 1.5 cm, the animals were euthanized using CO2. Tumors were isolated 
and cut it into small pieces followed by digestion using collagenase to prepare single cell 
suspension. The collected single cells were cultured in monolayer at 37°C, 5% CO2 in 
DMEM supplemented with 10% heat-inactivated FBS and 1% penicillin–streptomycin. 
Those Cr(VI)-transformed BEAS-2B cells (BEAS-2B-Cr) were used as a pool for selection 
of cancer stem cells. Briefly, after BEAS-2B-Cr were grown to 100% confluence, free-
floating cells were collected and cultured in defined keratinocyte serum-free medium in 
ultra-low attachment plates. After 6 days, spheroids formed by floating cells were collected 
and the cells were subcultured every 6 days. After 10 passages, those spheroid-derived cells 
which consistently formed spheres are considered as cancer stem cells (BEAS2B-Cr-CSC) 
and were used for experiments. The images of cell morphology were captured using 
Olympus IX73 microscope and cell size (area, μm2) was calculated using Olympus cellSens 
software.
Clonal assay
The clonal assay was performed as described previously (Plaisant et al., 2011). Both 
BEAS-2B-Cr and BEAS-2B-Cr-CSC were plated in 6-well plates at a density of 600 cells/
well and incubated for 7 days. The cells were fixed with 2% formalin for 10 min and stained 
with 0.5% crystal violet for 5 min. The images were captured using an Olympus IX73 
microscope.
Immunoblotting analysis
The cells were grown in 10-cm cell culture dishes. The cells were harvested and cell lysates 
were prepared in RIPA buffer. The protein concentration was measured using Bradford 
protein assay reagent. 20 μg of total protein from cell lysate was separated by SDS-PAGE 
flowered by incubation with primary antibody. The blots were then re-probed with second 
antibody conjugated to horseradish peroxidase. Proteins were visualized using an enhanced 
chemiluminescence kit.
Apoptosis Analysis
Annexin V/propidium iodide (PI) double staining was used to measure percentile of 
apoptosis according to manufacturer’s protocol. Briefly, the cells were seeded at 5×105 cells/
well in 6-well plates and treated with various concentrations of Cr(VI) or cisplatin for 24 
hours. The cells were washed with PBS and digested with 0.25% trypsin/EDTA followed by 
re-suspension in 500 μL of 1xbinding buffer and addition of Annexin V/PI. The apoptotic 
cells were measured using flow cytometry.
Detection of ROS
The cells were cultured in 96-well plates with 5×104 cells/well. The cells were treated with 
various concentrations of Cr(VI) or cisplatin for 24 hours and then incubated with 25 μM of 
H2DCFDA for 30 min at 37°C. The cells were washed twice with PBS. Fluorescence 
intensity was measured using a Gemini XPS fluorescence microplate spectrofluorometer 
(Molecular Devices). For FBP1 or vector-expressed cells, CellROX deep red reagent was 
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used as ROS detection probe and ROS level was measured using flow cytometry according 
to manufacturer’s protocol.
Measurement of glucose uptake
The cells were seeded at 5×105 cells/well in 6-well plates. Cells were starved in glucose- 
and serum-free media for 2 hours. The cells were then subsequently incubated with 100 μM 
of 2-deoxyglucose (2-DG) for 2 hours. After washing with PBS, cells were collected and 
glucose uptake (intracellular 2-DG level) was measured using a glucose uptake colorimetric 
assay kit (BioVision, Milpitas, CA) according to manufacturer’s protocol.
Measurement of lactate production
The cells were seeded at 1×105 cells/well in 24-well plates. Culture media was replaced with 
500 μL of fresh culture media and incubated for 24 hours. 400 μL of supernatant media was 
collected from the culture and the amount of lactate production was measured using a lactate 
colorimetric assay kit (BioVision, Milpitas, CA) according to manufacturer’s protocol.
Measurement of ATP content
To determine the intracellular ATP content, 1×106 cells were harvested and intracellular ATP 
concentration was measured using ATP assay kit (BioVision, Milpitas, CA) according to 
manufacturer’s protocol.
Mitochondrial member potential
Mitochondrial membrane potential (Δψm) was assessed using a JC-1 mitochondrial 
membrane potential assay kit (Cayman Chemical, Ann Arbor, MI) according to 
manufacturer’s protocol. Briefly, the cells were incubated with a JC-1 staining solution (1:10 
dilution) for 20 mins and washed with assay buffer twice. Then the fluorescence was 
detected using a Gemini XPS fluorescence microplate spectrofluorometer (Molecular 
Devices) at 488 nm excitation and 520 nm emission for green and 540 nm excitation and 
590 nm emission for red. The ratio of red/green uorescence was calculated.
Detection of oxygen consumption and glycolysis
Cellular oxygen consumption and glycolysis were assessed with a mitochondria stress test 
and a glycolysis stress test using a Seahorse XF-96 Flux Analyzer (Agilent Technologies, 
Santa Clara, CA), respectively. Cells were seeded in microplates with 90% confluence and 
grown for overnight. For mitochondria stress test, the cell growth media was replaced with 
175 uL of FX media (FX Assay Modified DMEM from Agilent Technologies with 5.5 mM 
glucose, 1 mM pyruvate and 2 mM glutamix) prior to the assay. Cells were washed once, 
media exchange was completed and then cells were equilibrated for 60 mins at 37°C in non-
CO2 incubator. Oxygen consumption rate (OCR) was measured four times and plotted as a 
function of cells under the basal condition followed by the sequential addition of three 
mitochondrial inhibitors: oligomycin A (1 mM), an ATP synthase inhibitor; carbonilcyanide 
p-triflouromethoxyphenylhydrazone (FCCP) (1 mM), an uncoupling agent; and a mixture of 
1 mM rotenone and 1 mM antimycin A, inhibitors for mitochondrial respiratory chain 
complex I and III to shut down the mitochondria oxygen consumption, respectively. To 
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allow comparison between cells, data are normalized and presented as OCR in 
pmoles/min/106 cells. For glycolysis stress test, non-glycolytic acidification was obtained in 
the absence of extracellular glucose and pyruvate. Next, cells were exposed to three 
compounds, with measurements of extracellular acidification rate (ECAR) after each 
injection. The first injection, a saturating concentration of glucose (10 mM), causes an 
increase in ECAR and defines the rate of glycolysis under basal conditions. The second 
injection, oligomycin (1 μM), inhibits mitochondrial respiration and shifts energy production 
toward glycolysis, revealing the maximum glycolytic capacity of the cells. The final 
injection, 2-deoxy-D-glucose (2-DG) (100 mM), inhibits glycolysis. The difference between 
maximum glycolytic capacity and glycolysis defines the glycolytic reserve. Data are 
normalized and presented as ECAR in mpH/min/106 cells.
Establishment of BEAS-2B-Cr-CSC with stably expressing FBP1
pLenti6.3/FBP1 was kindly provided by Dr. Binhua P. Zhou at the University of Kentucky. 
BEAS-2B-Cr-CSC were transfected with 4 μg plasmid using Lipofectamine 2000. The cells 
were selected using 2 μg/mL blasticidin for 1 month followed by immunoblotting analysis to 
verify FBP1 expression.
Real time PCR
RNA was extracted and purified using Qiagen RNeasy mini kit. 0.5 μg of RNA was 
reversely transcribed using M-MLV reverse transcriptase. Primers were designed using 
Primer-Blast yielding. Primers for human FBP1 are followed: Forward-CCC CAG ATA ATT 
CAG CTC CTT A and Reverse-GTT GCA TTC GTA CAG CAG TCT C. Values were 
normalized by GAPDH. Primers for GAPDH are followed: Forward-GCG AGA TCC CTC 
CAA AAT CAA and Reverse-GTT CAC ACC CAT GAC GAA CAT. PCR was performed 
using Perfecta Sybr Green Fastmix (Quanta Biosciences) in the CFX96 real-time PCR 
Detection System (Bio-Rad). Data were analyzed using CFX Manager software (Bio-Rad).
Tumorigenesis assay
Athymic nude mice (NU/NU, 6–8 weeks old, female) were purchased from The Jackson 
Laboratory (Bar Harbor, ME). The animals were housed in a pathogen-free room in the 
animal facilities at the Chandler Medical Center, University of Kentucky. All animals were 
handled according to the Institutional Animal Care and Use (IACUC) guidelines, University 
of Kentucky. The animals were randomly divided into the various groups with six animals of 
each group. Normal BEAS-2B cells, BEAS-2B-Cr, and BEAS-2B-Cr-CSC with or without 
forced expression of FBP1 were resuspended in serum-free medium with Matrigel basement 
membrane matrix (BD Biosciences) at a 1:1 ratio (total volume = 100 μL) and 
subcutaneously injected into the flanks of nude mice. Xenograft formation was examined 
every week up to 120 days. Tumors were measured using an external caliper and volume 
was calculated using the formula: (length x width2)/2. Tumor tissues were isolated and 
weighed. Freshly frozen and formalin fixed tumor tissues were used for immunoblotting and 
immunohistochemical staining, respectively. The implantation site containing a Matrigel 
plug, subcutaneous tissue, peritoneum, and skin was isolated to use as control tissue 
corresponding to the tumor tissues.
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Statistical analysis
Data were expressed as the mean ± standard deviation (SD). Fisher’s Exact Test was used to 
compare tumor incidence in tumorigenicity assay. In other assays, statistical significance of 
differences among treatment groups was determined by ANOVA with Student’s t test. A p < 
0.05 was considered as statistical significance.
Results
Isolation and characterization of spheroid-derived cells from Cr(VI)-transformed BEAS-2B 
cells
Our previous study has found that chronic exposure of human bronchial epithelial BEAS-2B 
cells to Cr(VI) causes malignant cell transformation and that those transformed cells are 
tumorigenic (Wang et al., 2011). Cancer stem cells exhibit stem cell-like properties and have 
been implicated in the tumorigenesis. To test whether a rare but constant fraction of cancer 
stem cells is present in Cr(VI)-transformed BEAS-2B cells (BEAS-2B-Cr), free-floating 
cells from confluent BEAS-2B-Cr were harvested and cultured in serum-free media under 
anchorage-independent growth condition. Spheroids with diameter ≥50 μm were formed 
within 7 days. Single cells harvested from enzymatically dissociated spheroids formed 
second spheroids under the same culture conditions. Those spheroid cells are considered as 
cancer stem cells (BEAS-2B-Cr-CSC). This procedure has been repeated for over 60 
passages with extensive amplification of cells. The morphology of BEAS-2B-Cr and 
BEAS-2B-Cr-CSC are shown in Fig. 1A. The average size of BEAS-2B-Cr-CSC was 4.5 
times smaller than that of BEAS-2B-Cr (data not shown). BEAS-2B-Cr-CSC exclusively 
formed holoclones with tightly packed smaller cells, whereas BEAS-2B-Cr formed 
meroclones with loosely packed larger cells (Fig. 1B). The average cell number in the 
BEAS-2B-Cr-CSC clones is 5.7 times less than that in the BEAS-2B-Cr ones after 7 days of 
culture (data not shown). Self-renewal genes Notch1 and p21 were highly expressed in both 
BEAS-2B-Cr and BEAS-2B-Cr-CSC compared to those in passage-matched normal cells 
(Fig. 1C). The expression levels of those two genes are much higher in BEAS-2B-Cr-CSC 
than those in BEAS-2B-Cr (Fig. 1C). Protein level of activator protein 1 (AP1) was 
increased in the BEAS-2B-Cr but it was deceased in BEAS2B-Cr-CSC (Fig. 1C). The above 
results suggest that a small population of cancer stem cells exist in Cr(VI)-transformed cells 
and those cancer stem cells possess a high self-renewal but a low proliferative potential.
The gold standard to evaluate activity of cancer stem cells is their capability to initiate 
serially transplantable tumor development (Tang et al., 2007). To determine tumor-initiating 
capacity of BEAS-2B-Cr-CSC, immunocompromised nude mice were injected with 
different cell number ranging from 1,000 to 500,000 cells. The results show that both 
BEAS-2B-Cr and BEAS-2B-Cr-CSC initiated tumor development in the nude mice (Fig. 
1D). BEAS-2B-Cr-CSC generated more tumors than BEAS-2B-Cr at cell number less than 
100,000. As few as 1,000 of BEAS-2B-Cr-CSC developed tumor in 6 out of a total of 6 
animals (100% tumor incidence) (Fig. 1D). The number of tumor was significantly reduced 
in the animals injected with 1,000 of BEAS-2B-Cr (2 out of a total of 6 animals, 33.3% 
tumor incidence). The results from pathohistological analysis showed that BEAS-2B-Cr-
CSC lost regular elongated shape of normal epithelial cells and exhibited significant nuclear 
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pleomorphism (Fig. 1E), indicating an enhanced malignancy. Those results suggest that 
BEAS-2B-Cr-CSC are highly tumorigenic and may be a major contributor in tumorigenesis 
of Cr(VI)-transformed cells.
Reduced capability to generate reactive oxygen species (ROS) and increased apoptosis 
resistance in BEAS-2B-Cr-CSC
Long-lived and quiescent potentials with high resistance to apoptosis are key characteristics 
of cancer stem cells. To evaluate whether BEAS-2B-Cr-CSC are resistant to apoptosis, 
passage-matched normal BEAS-2B cells, BEAS-2B-Cr, and BEAS-2B-CrSC were treated 
with Cr(VI) or cisplatin, a chemotherapeutical agent, and apoptosis was evaluated. The 
results showed the apoptosis induced by either Cr(VI) or cisplatin treatment in BEAS-2B-Cr 
was reduced compared to that in normal BEAS-2B cells (Fig. 2A). Treatment with 10 μM of 
Cr(VI) induced 47.4% and 18.7% of apoptosis in normal BEAS-2B cells and BEAS-2B-Cr, 
respectively, but it was unable to induce apoptosis (0.825%) in BEAS-2B-Cr-CSC (Fig. 2A, 
left). Similar results were observed when those cells were treated with cisplatin (Fig. 2A, 
right). Those results indicate that BEAS-2B-Cr-CSC are highly resistant to apoptosis. 
Further study showed levels of anti-apoptotic proteins Bcl-2 and Bcl-xL were dramatically 
elevated in both BEAS-2B-Cr and BEAS-2B-Cr-CSC compared to passage-matched normal 
cells and their expressions were much higher in BEAS-2B-Cr-CSC than those in BEAS-2B-
Cr (Fig. 2B).
Our previous study has demonstrated that ROS play a major role in Cr(VI)-induced cell 
transformation (Wang et al., 2011). Our previous study has also demonstrated that at early 
stage of Cr(VI)-induced carcinogenesis (cell transformation), excess amount of ROS is 
oncogenic and at late stage of Cr(VI)-carcinogenesis (progress of transformed cells to 
tumors), decreased level of ROS is carcinogenic (Kim et al., 2015). To explore the 
mechanism of apoptosis resistance in BEAS-2B-Cr-CSC, the cells were treated with Cr(VI) 
or cisplatin and ROS generation was measured. The results showed that basal ROS levels 
(without any treatment) in BEAS-2B-Cr and BEAS-2B-Cr-CSC were 0.43- and 0.31-fold of 
that in normal BEAS-2B cells, respectively (Fig. 2C). 10 μM of Cr(VI) treatment in normal 
cells induced a 8-fold increase in ROS generation compared to that without Cr(VI) 
treatment. It was 5-fold and 0.81-fold in BEAS-2B-Cr and BEAS-2B-Cr-CSC (Fig. 2C, 
left), respectively. These results indicate that extremely low capability to generate ROS may 
contribute to apoptosis resistance of BEAS-2B-Cr-CSC.
Because one of the major endogenous sources of ROS in eukaryotic cells is respiration in 
mitochondria, we examined oxygen consumption rate (OCR). As shown in Fig. 2D, basal 
OCR in both BEAS-2B-Cr and BEAS-2B-CSC were lower than that in passage-matched 
normal cells and the lowest basal OCR was found in BEAS-2B-Cr-CSC. Similar results 
were observed in ATP-linked and maximal OCR (Fig. 2D). Intracellular ROS level is 
controlled by endogenous ROS scavenging systems such as superoxide dismutase (SOD), 
NAD(P)H quinine oxidoreductase (NQO1). Our results showed that levels of both 
mitochondrial SOD (SOD2) and NQO1 were dramatically increased in BEAS-2B-Cr 
compared to those in the passage-matched normal ones and that the levels of those two 
enzymes were much higher in BEAS-2B-Cr-CSC (Fig. 2E). Altogether, these results reveal 
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that elevated levels of antioxidants and reduced ROS generation cause development of 
apoptosis resistance in BEAS-2B-Cr-CSC.
Elevation of glycolysis and loss of FBP1 in BEAS-2B-Cr-CSC
Reduced oxygen consumption may implicate aberrant energy metabolism, we further 
investigated glucose metabolism in BEAS-2B-Cr-CSC. The results showed that glucose 
uptake, lactate production, and intracellular ATP content in BEAS-2B-Cr-CSC were 17% 
(Fig. 3A), 43% (Fig. 3B), and 59% (Fig. 3C) of those in BEAS-2B-Cr, respectively, 
indicating that BEAS-2B-Cr-CSC are metabolically inactive. Compared to passage-matched 
normal cells, BEAS-2B-Cr exhibit an elevation of lactate production (Fig. 3B), suggesting a 
metabolic shift to glycolysis. Glucose uptake in BEAS-2B-Cr was increased (Fig. 3A) and 
ATP content was decreased by 9% as compared to those in normal BEAS-2B cells (Fig. 3C), 
which may due to the reduction in oxidative phosphorylation implicated by reduced OCR as 
shown in Fig. 2D. Mitochondrial potential (Δψm) remained the similar in BEAS-2B-Cr 
compared to that in passage-matched normal cells, but it was remarkably increased in 
BEAS-2B-Cr-CSC (Fig. 3D). It has been reported that expression of FBP1, a rate-limiting 
enzyme in gluconeogenesis, is reduced in many types of cancers including kidney cancer, 
liver cancer, colon cancer, and gastric cancer (Chen et al., 2011; Alderton, 2014). As shown 
in Fig. 3, FBP1 expression was reduced in BEAS-2B-Cr and was depleted in BEAS-2B-Cr-
CSC at both translational (Fig. 3D) and transcriptional level (Fig. 3E). Results from 
immunostaining analysis confirmed that FBP1 was lost in xenograft tumors generated by 
injection of BEAS-2B-Cr-CSC to animals (Fig. 3F).
FBP1 suppresses glycolysis and induces ROS generation, resulting in restored apoptosis 
in BEAS-2B-Cr-CSC
To investigate the role of FBP1 in maintaining cancer stem cell properties of BEAS-2B-Cr-
CSC, stable expression of FBP1 was established (Fig. 4A). Forced expression of FBP1 
reduced both glucose uptake and lactate production (Figs. 4B and 4C), indicating that FBP1 
antagonizes glycolysis. The results from ECAR analysis showed that forced expression of 
FBP1 decreased glycolysis and glycolytic capacity, but not glycolytic reserved capacity (Fig. 
4D). However, forced expression of FBP1 was unable to restore the oxygen consumption in 
BEAS-2B-Cr-CSC (4E). Basal, maximal, and ATP-linked OCR were all reduced by ectopic 
FBP1 (Fig. 4E). Those results indicates the inhibition on oxidative phosphorylation and 
reduction of oxygen consumption in BEAS-2B-Cr-CSC.
Forced FBP1 expression increased ROS generation and apoptosis induced by Cr(VI) and 
cisplatin in BEAS-2B-Cr-CSC (Figs. 5A and 5B). Expressions of anti-apoptotic proteins 
Bcl-2 and Bcl-xL were reduced in BEAS-2B-Cr-CSC with FBP1 overexpression compared 
with scramble cells (Fig. 5C). Cr(VI) treatment increased levels of cleaved PARP (C-PARP), 
cleaved caspase-3 (C-caspase 3), and cleaved caspase-9 (C-caspase 9) in BEAS-2B-Cr-CSC 
(Fig. 5C). Forced FBP1 expression reduced expressions of apoptotic proteins Bcl-2 and Bcl-
xL in BEAS-2B-Cr-CSC compared to those in scramble cells (Fig. 5C). In addition, SOD2 
level was also reduced in BEAS-2B-Cr-CSC with forced FBP1 expression (Fig. 5C). Those 
results indicate that FBP1 restores capability of generating ROS in BEAS-2B-Cr-CSC and 
reduces antioxidants level, leading to increased apoptosis.
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FBP1 suppresses tumorigenesis of BEAS-2B-Cr-CSC
We note that Notch1 and p21, two cell self-renewal genes, were upregulated in BEAS-2B-
Cr-CSC (Fig. 1C). Next, we investigated whether FBP1 plays a role in upregulations of 
Notch1 and p21 in BEAS-2B-Cr-CSC. The results from immunoblotting analysis showed 
that both Notch 1 and p21 expressions were decreased in BEAS-2B-Cr-CSC with forced 
FBP1 expression compared to those in scramble cells (Fig. 6A). In contrast, forced 
expression of FBP1 was able to partially restore AP1 expression which was dramatically 
reduced in BEAS-2B-CSC cells (Fig. 6A). To further study the role of FBP1 in 
tumorigenesis of BEAS-2B-Cr-CSC in vivo, 1,000 of BEAS-2B-Cr-CSC with or without 
forced FBP1 expression were subcutaneously injected into the immunocompromised nude 
mice. The results show that 4 out of a total of 6 animals (66.7%) injected with FBP1-
expressed BEAS-2B-Cr-CSC developed tumor after 120 days whereas 6 out of 6 (100%) 
injected with scramble BEAS-2B-Cr-CSC developed tumor (Fig. 6B). Both tumor weight 
and volume were significantly reduced in FBP1-expressed BEAS-2B-Cr-CSC compared to 
the scramble cells (Figs. 6B and 6C). Expressions of Notch1 and p21 were both reduced in 
the tumor tissue injected with BEAS-2B-Cr-CSC with forced FBP1 expression (Figs. 6D 
and 6E). AP1 level was elevated in the tumor tissues injected with FBP1 expressing cells 
(Figs. 6D and 6E). Those results suggest that FBP1 decreases expressions of Notch1 and 
p21, elevates level of AP1, and suppresses tumorigenesis of BEAS-2B-Cr-CSC.
Discussion
Cancer cells are derived hierarchically from a small subset of malignant cells that have a 
high capacity of self-renewal and differentiation—referred to cancer stem cells (CSCs) or 
cancer-initiating cells. CSCs exhibit stem cell-like properties and have been implicated in 
the tumorigenesis of basal like breast cancer, a particularly aggressive, metastatic and 
chemotherapy-resistant type of breast cancer (Schieber and Chandel, 2013). In the present 
study, we have observed that a minor fraction (about 1%) of the cells established a holoclone 
in Cr(VI)-transformed cells. A holoclone, a tightly packed clone, contains stem cells and 
progenitors (Locke et al., 2005). These holoclones can be subcloned and propagated, 
indicating the presence of self-renewing cells in the clones (Tang et al., 2007). Such a 
smaller fraction of cells survived and formed a sphere in anchorage independent assay, 
confirming existing of cancer stem-like cells in Cr(VI)-transformed cells. CSCs exhibit an 
enhanced capacity to initiate and sustain tumor growth, which is crucial for the progression 
and relapse of malignant tumors (Visvader and Lindeman, 2008). The present study has 
demonstrated that those CSCs are tumorigenic as evidenced development of tumor in the 
nude mice injected with as few as 1,000 cells.
Notch signaling is an important regulator in balance between self-renewal and differentiation 
in normal stem cells. How CSCs are maintained in a heterogeneous tumor is unknown. One 
potential contributor is the Notch signaling. It has been reported that inhibition of Notch 
signaling led to a decrease in CSCs number and impairs CSCs function (Abel et al., 2014). It 
has also been reported that p21, a cell cycle inhibitor, is critical in maintaining self-renewal 
of leukemia stem cells (Viale et al., 2009). Activation of p21 imposes cell cycle restriction 
and triggers repair of the damaged DNA, resulting in initiation and maintenance of leukemia 
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(Viale et al., 2009). The present study has shown that expressions of both Notch1 and p21 
are elevated in Cr(VI)-transformed cells compared to those in passage-match normal cells. 
Their expressions are even higher in BEAS-2B-Cr-CSC than those in Cr(VI)-transformed 
cells, indicating the high capacity of self-renewal and differentiation of BEAS-2B-Cr-CSC. 
AP1, a transcript factor, is a homodimer or heterodimer composed of c-Jun and c-Fos 
families. AP1 is involved in multiple cellular processes, such as differentiation, proliferation, 
and apoptosis (Ameyar et al., 2003; Hess et al., 2004). It has been reported that activation of 
c-Jun facilitates entry of the cells into G1 and S phases of cell cycle (Bakiri et al., 2000). c-
Jun also controls anti-proliferative cell cycle regulators such as p53 (Weitzman et al., 2000) 
and p21 (Shaulian and Karin, 2001). The results from the present study showed that protein 
level of AP1 was elevated in the Cr(VI)-transformed cells, but it was reduced in BEAS-2B-
CSC. It has also reported that suppression of either c-Fos or c-Jun increases expressions of 
stemness transcription factors NANOG and SOX2 in colorectal cancer cells (Apostolou et 
al., 2013). Elevation of AP1 in Cr(VI)-transformed cells may promote cell growth and 
proliferation. Reduction of AP1 in BEAS-2B-Cr-CSC causes the cell cycle restriction, 
maintaining stemness.
CSCs contain lower ROS levels than their corresponding non-tumorigenic cells (Diehn et al., 
2009; Ye et al., 2011). Low levels of ROS, which are thought to be the byproducts of 
mitochondrial biogenesis, are required for haemopoietic stem cells (HSCs) to remain 
quiescent and retain their stem features, such as self-renewal potential and multipotency 
(Chen et al., 2009). The low levels of ROS in CSCs are associated with elevated expressions 
of free radical scavenging systems (Zhou et al., 2003; Diehn et al., 2009). The strong 
antioxidant defense helps in the maintenance of stemness and tumourigenic capacities of 
CSCs, causing therapy resistance (Diehn et al., 2009; Pasto et al., 2014). The present study 
has observed that the BEAS-2B-Cr-CSC were resistant to apoptosis irritated by Cr(VI) and 
by cisplatin and that capacity of generating ROS in BEAS-2B-Cr-CSC were dramatically 
reduced. It should be noted that reduced capacity of generating ROS is one of the major 
players for apoptosis resistance of BEAS-2B-Cr-CSC. Further study has found that levels of 
antioxidant enzymes SOD2 and NQO1 are upregulated in BEAS-2B-Cr-CSC. Nuclear factor 
erythroid-related factor 2 (Nrf2), a transcription factor, is a master regulator of intercellular 
ROS. Nrf2 mediates the expression of cytoprotective genes, including glutathione, 
thioredoxin, heme oxygenase-1, NQO1, and the members of the glutathione-S-transferase 
family. Constitutive expression of Nrf2 is prominent in several types of human cancer cell 
lines and tumors (Tong et al., 2006; Ohta et al., 2008; Lau et al., 2013). Nrf2 may help in 
maintaining the quiescence of hematopoietic stem cells by maintaining a reduced redox state 
(Shi et al., 2012). Our preliminary study has observed that Nrf2 is constitutively activated in 
BEAS-2B-Cr-CSC. Constitutive activation of Nrf2 further causes the upregulation of its 
downstream cytoprotective proteins SOD2 and NQO1, resulting in reduced generation of 
ROS, leading to development of apoptosis resistance. Constitutively activated Nrf2 binds to 
AREs of Bcl-2 and Bcl-xL gene promoters, leading to up-regulations of antiapoptotic Bcl-2 
and Bcl-XL and development of resistance to apoptosis (Calvert et al., 2009; Niture and 
Jaiswal, 2012; Son et al., 2015). Our unpublished results have shown that binding of Nrf2 to 
AREs in the promoters of Bcl-2, Bcl-xL, SOD2, and NOQ1 in Cr(VI)-transformed cells 
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were markedly increased. We anticipate that the similar observations will be obtained in 
BEAS-2B-Cr-CSC as those in BEAS-2B-Cr.
Metabolic adaptation is one of the hallmarks of cancer cells. Glycolysis is the enzymatic 
conversion of glucose into lactate, which produces 2 molecules of ATP per molecule of 
glucose. In the presence of oxygen, cells adopt oxidative phosphorylation as a major 
pathway to produce energy, more efficiency than glycolysis since it generates 36 molecules 
of ATP per molecule of glucose. Cancer cells generate ATP via glycolysis even under 
normoxic concentrations known as the Warburg effect (Peiris-Pages et al., 2016). Glycolysis 
produces ATP more rapidly than OXPHOS in the presence of abundant glucose (Guppy et 
al., 1993). Compared to the passage-matched normal BEAS-2B cells, Cr(VI)-transformed 
cells generated more lactate without significant changes in glucose uptake and ATP 
production, indicating a switch from mitochondrial respiration to a metabolism that is 
mainly glycolytic.
It has been reported that CSCs are less glycolytic, consume less glucose, produce less 
lactate, and maintain higher ATP levels than their differentiated progeny. However, other 
studies have reported that CSCs are more glycolytic than their differentiated cancer cells, 
glucose uptake, expression of glycolytic enzymes, lactate production, and ATP content are 
all significantly increased (Ciavardelli et al., 2014; Palorini et al., 2014). This glycolytic 
phenotype is associated with a decrease in mitochondrial oxidative metabolism (Zhou et al., 
2011). In the present study we have shown that glucose uptake, lactate production, and ATP 
content were all remarkably reduced in BEAS-2B-Cr-CSC compared to normal cells and 
Cr(VI)-transformed cells, indicating metabolic inactiveness of those CSCs. The 
mitochondria of CSCs have an increased mass and membrane potential, which reflects 
mitochondrial function, higher mitochondrial ROS and enhanced oxygen consumption rates 
compared with the differentiated cancer cells (Lagadinou et al., 2013; Pasto et al., 2014; De 
Luca et al., 2015; Lamb et al., 2015; Sancho et al., 2015). Another study has reported the 
lower quantity of mitochondrial DNA, higher mitochondrial potential, lower oxygen/glucose 
consumption, and lower intracellular levels of ROS and ATP content in CSCs isolated from 
adenocarcinomic human alveolar basal epithelial A549 cells (Ye et al., 2011). In the present 
study, we have observed reduced levels of both mitochondrial and non-mitochondrial OCR 
in BEAS-2B-Cr-CSC, further showing that those CSCs are in low energy demanding. A 
higher Δψm is an indicator of transformation, differentiation status, and tumorigenicity. 
Although the present study has not detected the mitochondrial mass yet, our results showed 
a dramatic elevation of Δψm in BEAS-2B-Cr-CSC compared to those in passage-matched 
normal cells and in Cr(VI)-transformed cells. The mechanism of high Δψm in CSCs is 
unknown, one possibility is the overexpression of Bcl-2 family. It has been reported that the 
interaction of Bcl-2 and Bcl-xL with permeability transition pore complex (PTPC) facilitates 
closure and maintenance of Δψm (Sugrue and Tatton, 2001). In BEAS-2B-Cr-CSC, both 
Bcl-2 and Bcl-xL are highly expressed. High levels of Bcl-2 and Bcl-xL may explain the 
high Δψm of BEAS-2B-Cr-CSC. ROS, acting on thiols in the PTPC, facilitates opening of 
PTPC and shifts the intracellular Δψm (Klein et al., 1996). The low levels of ROS may be 
another possibility for the high Δψm in BEAS-2B-Cr-CSC.
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FBP1 is a rate-limiting enzyme in gluconeogenesis. It has been reported that FBP1 
inhibition increased glucose uptake and lactate secretion in HK-2 human renal cells (Li et 
al., 2014). Ectopic FBP1 expression in a VHL-deficient renal carcinoma RCC10 cells 
reduced glucose uptake, lactate secretion, and glucose-derived TCA cycle intermediates (Li 
et al., 2014). We manipulated FBP1 expression in BEAS-2B-Cr-CSC and measured glucose 
metabolism. Forced expression of FBP1 causes reductions of glucose uptake, lactate 
production, and glycolysis, indicating that FBP1 is a critical regulator of glucose metabolism 
in BEAS-2B-Cr-CSC. However, forced expression of FBP1 failed to restore the oxygen 
consumption. Our preliminary data showed in BEAS-2B-Cr mitochondria was defected. We 
speculate that chronic exposure of BEAS-2B cells to Cr(VI) causes mitochondrial damage 
and subsequently inhibition of mitochondrial oxidative phosphorylation in BEAS-2B-Cr and 
BEAS-2B-Cr-CSC, which could not be restored by ectopic expression of FBP1.
Reduced level of FBP1 is associated with tumor progression and poor prognosis (Li et al., 
2014; Hirata et al., 2016), suggesting that FBP1 may act as tumor suppressor gene in 
addition to its enzymatic function. Loss of FBP1 has also been reported to inhibit ROS 
production, resulting in an increased CSC-like property and tumorigenicity of breast cancer 
cells (Dong et al., 2013). Ectopic expression of FBP1 in breast cancer cells diminished 
tumor growth in mice (Dong et al., 2013). FBP1 inhibited HIF function by direct interaction 
with HIF inhibitory domain, leading to suppression of proliferation of renal carcinoma cells 
(Li et al., 2014). We have observed that forced expression of FBP1 restored the capacity of 
generating ROS and decreased SOD2 protein level in BEAS-2B-Cr-CSC. We have also 
observed that forced expression of FBP1 decreased levels of anti-apoptotic proteins Bcl-2 
and Bcl-xL and elevated levels of apoptotic proteins C-PARP, C-caspase 3, and C-caspase 9 
in BEAS-2B-Cr-CSC. The results from our preliminary study showed that forced expression 
of FBP1 in BEAS-2B-Cr-CSC decreased Nrf2 level. Reduction in Nrf2 may cause decreases 
of SOD2, Bcl-2, and Bcl-xL through decreased binding of Nrf2 to AREs in their promoters, 
resulting in increased apoptosis, leading to inhibition of tumorigenesis. Forced expression of 
FBP1 also decreased levels of self-renewal genes Notch1 and p21 and increased cyclin D1 
level, promoting cell cycle and reducing stemness. The mechanism of FBP1 on Notch1 and 
p21 needs to be further investigated.
In conclusion, the present study has observed that a small population of cancer stem cells is 
the driving force for tumorigenecity of Cr(VI)-transformed cells. Those cells exhibit low 
metabolic activity, reduced ROS production, diminished FBP1 level, and increased levels of 
mitochondrial antioxidant SOD2 and anti-apoptotic proteins Bcl-2 and Bcl-xL. Ectopic 
expression of FBP1 (a) suppresses glycolysis; (b) decreases levels of SOD2; (c) restores 
capacity of generating ROS; (d) decreases levels of Bcl-2 and Bcl-xL; and (e) reduces levels 
of Notch1 and p21, diminishing stemness. FBP1 functions both as an enzyme of 
glycogenesis in maintenance of low glucose metabolism and as a tumor suppressor in 
maintenance of both low ROS level and high self-renewal, contributing to tumorigenesis of 
Cr(VI)-transformed cells.
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AP1 activator protein 1
Cr(VI) hexavalent chromium
CSCs cancer stem cells
2-DG 2-deoxy-D-glucose
ECAR extracellular acidification rate
FBP1 fructose-1,6- bisphosphatase
FCCP carbonilcyanide p-triflouromethoxyphenylhydrazone
H2DCFDA 5-(and -6)-chloromethyl-2, 7-dichlorodihydrofluorescein diacetate, acetyl 
ester
NQO1 NAD(P)H dehydrogenase (quinone) 1
Nrf2 nuclear factor erythroid-related factor 2
OCR oxygen consumption rate
OXPHOS catabolic glycolysis/oxidative phosphorylation
PTPC permeability transition pore complex
ROS reactive oxygen species
SOD superoxide dismutase
SOX2 sex determining region Y-box 2
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Highlights
• A small population of cancer-like stem cells exist in Cr(VI)-transformed cells.
• Those cancer-like stem cells are low in ROS levels and resistant to apoptosis.
• Those cancer-like stem cells are metabolic inactive and loss of FBP1.
• Those cancer-like stem cells initiate and sustain tumor growth.
• Forced expression of FBP1 inhibits tumorigenecity of those cancer-like stem 
cells.
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Figure 1. 
Isolation and characterization of cancer-like stem cells (BEAS2B-Cr-CSC) from Cr(VI)-
transformed BEAS-2B cells (BEAS-2B-Cr). (A) Representative images of BEAS-2B-Cr 
(monolayer) and BEAS-2B-Cr-CSC (spheroids). (B) Representative images of single clone 
formed by BEAS-2B-Cr (meroclone) and BEAS-2B-Cr-CSC (holoclone). (C) BEAS-2B, 
BEAS-2B-Cr, and BEAS-2B-Cr-CSC were harvested and whole protein lysates were 
isolated. Expression of Notch1, p21, and AP1 were examined using immunoblotting 
analysis. (D) and (E) Xenograft tumor growth. 6–8 week old, female immunocompromised 
nude mice were randomly divided into eight groups with six animals of each group. The 
animals were subcutaneously injected the various cell types and cell numbers as indicated. 
90 days after implantation, the animals were euthanized and tumors were isolated. The 
images of tumors were captured (D). * p<0.05 compared to BEAS-2B-Cr group. Tumor 
tissues were fixed in 10% formalin. Tissue sections were subjected to hematoxylin/eosin 
(HE) staining (E). The results are representative of three independent experiments.
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Figure 2. 
Reduced ROS generation and apoptosis resistance of BEAS2B-Cr-CSC. (A) Passage-
matched normal BES-2B cells, BEAS-2B-Cr, and BEAS-2B-Cr-CSC were treated with 
various doses of Cr(VI) or cisplatin for 24 hours. Apoptosis was determined by Annexin 
V/PI using flow cytometry. (B) and (E) BEAS-2B, BEAS-2B-Cr, and BEAS-2B-Cr-CSC 
were harvested and whole protein lysates were isolated for examination of expressions of 
anti-apoptotic proteins Bcl-2 and Bcl-xL (B) and antioxidant enzymes SOD2 and NQO1 (E). 
The results are representative of three independent experiments. (C) Intracellular ROS levels 
were measured by DCFDA fluorescence using a fluorescence microplate reader. Data were 
normalized as compared with the ROS level in BEAS-2B cells without treatment. * and #, 
p<0.05 compared to BEAS-2B and BEAS-2B-Cr, respectively. (D) BEAS-2B, BEAS-2B-Cr, 
and BEAS-2B-Cr-CSC were subjected to mitochondria stress assay with real time oxygen 
consumption rate (OCR) measurements using a Seahorse XF-96 Flux Analyzer. Data were 
normalized and presented as OCR in pmoles/min/106 cells. * and #, p<0.05 compared to 
BEAS-2B and BEAS-2B-Cr, respectively.
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Figure 3. 
Elevation of glycolysis and loss of FBP1 in BEAS-2B-Cr-CSC. Glucose uptake (A), lactate 
production (B), intracellular ATP contents (C), and (D) mitochondria membrane potential 
(Δψm, red/green ratio) were measured as described in the Materials and Methods. BEAS-2B 
cells, BEAS-2B-Cr, and BEAS-2B-Cr-CSC were harvested. Whole protein lysates (E) and 
mRNA (F) were isolated. Expression of FBP1 was examined using immunoblotting analysis 
(E) and real-time PCR (F). * and #, p<0.05 compared to BEAS-2B and BEAS-2B-Cr cells, 
respectively. (G) Representative immunohistological staining for FBP1 expression in the 
tumor tissues from BEAS-2B-Cr and BEAS-2B-Cr-CSC. The results are representative of 
three independent experiments.
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Figure 4. 
FBP1 downregulates glycolysis but fails to restore oxygen consumption in BEAS-2B-Cr-
CSC. (A) BEAS-2B-Cr-CSC were transfected with pLenti6.3/FBP1 followed by antibiotic 
selection for 1 month. The cells were harvested for examination of FBP1 expression using 
immunoblotting analysis. The results are representative of three independent experiments. 
Glucose uptake (B) and lactate production (C) in BEAS-2B-Cr-CSC with or without 
expression of FBP1 were measured as described in the Materials and Methods. (D) and (E) 
BEAS-2B-Cr-CSC with or without expression of FBP1 were subjected to glycolysis or 
mitochondria stress assay. Extracellular acidification rate (ECAR) (D) and oxygen 
consumption rate (OCR) (E) were measured using a Seahorse XF-96 Flux Analyzer. Data 
were normalized and presented as ECAR in mpH/min/106 cells and OCR in pmoles/min/106 
cells. * p<0.05 compared to BEAS-2B-Cr-CSC.
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Figure 5. 
FBP1 increases ROS generation and restores apoptosis of BEAS-2B-Cr-CSC. (A) and (B) 
BEAS-2B-Cr-CSC with or without expression of FBP1 were treated with various doses of 
Cr(VI) or cisplatin for 24 hours. Apoptosis was determined by Annexin V/PI using flow 
cytometry (A). Intracellular ROS levels were measured by CellRox deep red reagent using 
flow cytometry (B). Data were normalized as compared with BEAS-2B-Cr-CSC. * p<0.05 
compared to BEAS-2B-Cr-CSC. (C) BEAS-2B-Cr-CSC with and without FBP1 
overexpression were harvest and whole protein lysates were isolated. Expressions of 
apoptotic, anti-apoptotic, and antioxidant proteins were examined using immunoblotting. 
The results are representative of three independent experiments.
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Figure 6. 
FBP1 suppresses tumorigenesis of BEAS-2B-Cr-CSC. (A) BEAS-2B-Cr-CSC with and 
without FBP1 overexpression were collected. Whole cell lysates were isolated to examine 
expressions of Notch1, p21, and AP1. (B)–(E) 6–8 week old, female immunocompromised 
nude mice were randomly divided into two groups with six animals of each group. 1,000 of 
BEAS-2B-Cr-CSC with or without expression of FBP1 were subcutaneously injected in to 
athymic nude mice. At 120 days after implantation, animals were euthanized and xenograft 
tumors were isolated. Pictures were captured, tumors were weighted (B), and tumor volume 
were measured (C). One portion of tumor tissues was fixed in 10% formalin and another 
portion was freshly frozen at −80°C freezer. Tissue sections were used to examine 
expressions of Notch1, p21, and AP1 using immunohistological staining (D) and using 
immunoblotting analysis (E). The results are representative of three independent 
experiments.
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